Pretreatment Lipoprotein(a) as a Biomarker for EGFR Mutation and Prognosis in Lung Adenocarcinoma.
Liu J, Liu Z, Xu D, Zhou T, Li A, Hu J, Li H, Li W, Wang Z, Yu Z, Zeng L.
Liu J, et al. Among authors: li w, li h, li a.
Int J Gen Med. 2024 Dec 27;17:6465-6478. doi: 10.2147/IJGM.S501401. eCollection 2024.
Int J Gen Med. 2024.
PMID: 39742033
Free PMC article.